Yue Zhao

Sizhe Liu, Yizhou Lu, Siyu Chen et al.

Recent progress in Large Language Models (LLMs) has drawn attention to their potential for accelerating drug discovery. However, a central problem remains: translating theoretical ideas into robust implementations in the highly specialized context of pharmaceutical research. This limitation prevents practitioners from making full use of the latest AI developments in drug discovery. To address this challenge, we introduce DrugAgent, a multi-agent framework that automates machine learning (ML) programming for drug discovery tasks. DrugAgent employs an LLM Planner that formulates high-level ideas and an LLM Instructor that identifies and integrates domain knowledge when implementing those ideas. We present case studies on three representative drug discovery tasks. Our results show that DrugAgent consistently outperforms leading baselines, including a relative improvement of 4.92% in ROC-AUC compared to ReAct for drug-target interaction (DTI). DrugAgent is publicly available at https://anonymous.4open.science/r/drugagent-5C42/.

Yiling Wang, Elia Lombardo, Adrian Thummerer et al.

Purpose: Magnetic resonance imaging (MRI) to visualize anatomical motion is becoming increasingly important when treating cancer patients with radiotherapy. Hybrid MRI-linear accelerator (MRI-linac) systems allow real-time motion management during irradiation. This paper presents a multi-institutional real-time MRI time series dataset from different MRI-linac vendors. The dataset is designed to support developing and evaluating real-time tumor localization (tracking) algorithms for MRI-guided radiotherapy within the TrackRAD2025 challenge (https://trackrad2025.grand-challenge.org/). Acquisition and validation methods: The dataset consists of sagittal 2D cine MRIs in 585 patients from six centers (3 Dutch, 1 German, 1 Australian, and 1 Chinese). Tumors in the thorax, abdomen, and pelvis acquired on two commercially available MRI-linacs (0.35 T and 1.5 T) were included. For 108 cases, irradiation targets or tracking surrogates were manually segmented on each temporal frame. The dataset was randomly split into a public training set of 527 cases (477 unlabeled and 50 labeled) and a private testing set of 58 cases (all labeled). Data Format and Usage Notes: The data is publicly available under the TrackRAD2025 collection: https://doi.org/10.57967/hf/4539. Both the images and segmentations for each patient are available in metadata format. Potential Applications: This novel clinical dataset will enable the development and evaluation of real-time tumor localization algorithms for MRI-guided radiotherapy. By enabling more accurate motion management and adaptive treatment strategies, this dataset has the potential to advance the field of radiotherapy significantly.

Haoyan Xu, Zhengtao Yao, Ziyi Wang et al.

Out-of-distribution (OOD) detection in graphs is critical for ensuring model robustness in open-world and safety-sensitive applications. Existing graph OOD detection approaches typically train an in-distribution (ID) classifier on ID data alone, then apply post-hoc scoring to detect OOD instances. While OOD exposure - adding auxiliary OOD samples during training - can improve detection, current graph-based methods often assume access to real OOD nodes, which is often impractical or costly. In this paper, we present GOE-LLM, a framework that leverages Large Language Models (LLMs) to achieve OOD exposure on text-attributed graphs without using any real OOD nodes. GOE-LLM introduces two pipelines: (1) identifying pseudo-OOD nodes from the initially unlabeled graph using zero-shot LLM annotations, and (2) generating semantically informative synthetic OOD nodes via LLM-prompted text generation. These pseudo-OOD nodes are then used to regularize ID classifier training and enhance OOD detection awareness. Empirical results on multiple benchmarks show that GOE-LLM substantially outperforms state-of-the-art methods without OOD exposure, achieving up to a 23.5% improvement in AUROC for OOD detection, and attains performance on par with those relying on real OOD labels for exposure.